Sign up today and learn more about Zymergen Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Zymergen Stock
Zymergen researches, develops, and manufactures microbes for companies. It develops molecules for agriculture, chemicals, materials, pharmaceuticals, electronics, personal care, and more applications. Zymergen’s platform integrates automation, machine learning, and genomics to navigate the genomic search space. It uses a technology platform to optimize microbial strains that aims to improve economics of in-market products, existing production strains within existing manufacturing processes, and the correlation between the lab and commercial manufacturing. Moreover, Zymergen offers new product development, such as engineering any molecules from any microbes that improves the power of biology to develop novel products.
Jed Dean, Joshua J. Hoffman, and Zachary Serber founded the company in 2013, with headquarters in Emeryville in California and an additional office in Seattle in Washington.
Chief Executive Officer
Chief Technology Officer